196 related articles for article (PubMed ID: 35271934)
1. The calcium-sensing receptor stabilizes podocyte function in proteinuric humans and mice.
Mühlig AK; Steingröver J; Heidelbach HS; Wingerath M; Sachs W; Hermans-Borgmeyer I; Meyer-Schwesinger C; Choi HY; Lim BJ; Patry C; Hoffmann GF; Endlich N; Bracke K; Weiß M; Guse AH; Lassé M; Rinschen MM; Braun F; Huber TB; Puelles VG; Schmitt CP; Oh J
Kidney Int; 2022 Jun; 101(6):1186-1199. PubMed ID: 35271934
[TBL] [Abstract][Full Text] [Related]
2. Should we consider calcimimetics as a therapeutic option for nephrotic syndrome?
Lenoir O; Tharaux PL
Kidney Int; 2022 Jun; 101(6):1110-1112. PubMed ID: 35597590
[TBL] [Abstract][Full Text] [Related]
3. Calcium-Sensing Receptor Stimulation in Cultured Glomerular Podocytes Induces TRPC6-Dependent Calcium Entry and RhoA Activation.
Zhang L; Ji T; Wang Q; Meng K; Zhang R; Yang H; Liao C; Ma L; Jiao J
Cell Physiol Biochem; 2017; 43(5):1777-1789. PubMed ID: 29050010
[TBL] [Abstract][Full Text] [Related]
4. Loss of the podocyte glucocorticoid receptor exacerbates proteinuria after injury.
Zhou H; Tian X; Tufro A; Moeckel G; Ishibe S; Goodwin J
Sci Rep; 2017 Aug; 7(1):9833. PubMed ID: 28852159
[TBL] [Abstract][Full Text] [Related]
5. IP
Xu H; Guan N; Ren YL; Wei QJ; Tao YH; Yang GS; Liu XY; Bu DF; Zhang Y; Zhu SN
BMC Nephrol; 2018 Jun; 19(1):140. PubMed ID: 29907098
[TBL] [Abstract][Full Text] [Related]
6. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
7. Non-canonical Wnt/calcium signaling is protective against podocyte injury and glomerulosclerosis.
Zhou D; Wang Y; Gui Y; Fu H; Zhou S; Wang Y; Bastacky SI; Stolz DB; Liu Y
Kidney Int; 2022 Jul; 102(1):96-107. PubMed ID: 35341792
[TBL] [Abstract][Full Text] [Related]
8. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
9. Melanocortin therapy ameliorates podocytopathy and proteinuria in experimental focal segmental glomerulosclerosis involving a podocyte specific non-MC1R-mediated melanocortinergic signaling.
Qiao Y; Wang P; Chang M; Chen B; Ge Y; Malhotra DK; Dworkin LD; Gong R
Clin Sci (Lond); 2020 Apr; 134(7):695-710. PubMed ID: 32167144
[TBL] [Abstract][Full Text] [Related]
10. IL-1 receptor signaling in podocytes limits susceptibility to glomerular damage.
Ren J; Lu X; Hall G; Privratsky JR; Robson MJ; Blakely RD; Crowley SD
Am J Physiol Renal Physiol; 2022 Feb; 322(2):F164-F174. PubMed ID: 34894725
[TBL] [Abstract][Full Text] [Related]
11. Synaptopodin Limits TRPC6 Podocyte Surface Expression and Attenuates Proteinuria.
Yu H; Kistler A; Faridi MH; Meyer JO; Tryniszewska B; Mehta D; Yue L; Dryer S; Reiser J
J Am Soc Nephrol; 2016 Nov; 27(11):3308-3319. PubMed ID: 27020855
[TBL] [Abstract][Full Text] [Related]
12. Protein tyrosine phosphatase 1B inhibition protects against podocyte injury and proteinuria.
Kumagai T; Baldwin C; Aoudjit L; Nezvitsky L; Robins R; Jiang R; Takano T
Am J Pathol; 2014 Aug; 184(8):2211-24. PubMed ID: 24951831
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
14. Podocyte-specific NF-κB inhibition ameliorates proteinuria in adriamycin-induced nephropathy in mice.
Yamashita M; Yoshida T; Suzuki S; Homma K; Hayashi M
Clin Exp Nephrol; 2017 Feb; 21(1):16-26. PubMed ID: 27089875
[TBL] [Abstract][Full Text] [Related]
15. Podocyte Geranylgeranyl Transferase Type-I Is Essential for Maintenance of the Glomerular Filtration Barrier.
Boi R; Bergwall L; Ebefors K; Bergö MO; Nyström J; Buvall L
J Am Soc Nephrol; 2023 Apr; 34(4):641-655. PubMed ID: 36735952
[TBL] [Abstract][Full Text] [Related]
16. Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance.
Tian X; Kim JJ; Monkley SM; Gotoh N; Nandez R; Soda K; Inoue K; Balkin DM; Hassan H; Son SH; Lee Y; Moeckel G; Calderwood DA; Holzman LB; Critchley DR; Zent R; Reiser J; Ishibe S
J Clin Invest; 2014 Mar; 124(3):1098-113. PubMed ID: 24531545
[TBL] [Abstract][Full Text] [Related]
17. The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.
Li C; Ge Y; Dworkin L; Peng A; Gong R
J Pathol; 2016 May; 239(1):23-35. PubMed ID: 26876299
[TBL] [Abstract][Full Text] [Related]
18. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
19. CXCR4 induces podocyte injury and proteinuria by activating β-catenin signaling.
Mo H; Ren Q; Song D; Xu B; Zhou D; Hong X; Hou FF; Zhou L; Liu Y
Theranostics; 2022; 12(2):767-781. PubMed ID: 34976212
[No Abstract] [Full Text] [Related]
20. Podocyte-specific knockout of myosin 1e disrupts glomerular filtration.
Chase SE; Encina CV; Stolzenburg LR; Tatum AH; Holzman LB; Krendel M
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1099-106. PubMed ID: 22811491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
